Rhuana Valdetario Valdetário Medice

Dr. Rhuana Valdetario Valdetário Medice

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2020 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
Rhuana Valdetario Valdetário MediceRhuana Valdetario Valdetário Medice
Rhuana Valdetario Valdetário Medice
RARobson José de Cássia Franco Afonso
Robson José de Cássia Franco Afonso
MAMarys Lene Braga Almeida
Marys Lene Braga Almeida
SASérgio Francisco Aquino
Sérgio Francisco Aquino
MLMarcelo Libanio
Marcelo Libanio

1 October 2024 in Environmental Toxicology and Chemistry
Verified
Journal Article
Closed access
Rhuana Valdetario Valdetário MediceRhuana Valdetario Valdetário Medice
Rhuana Valdetario Valdetário Medice
RARenan Silva Arruda
Renan Silva Arruda
JYJaewon Yoon
Jaewon Yoon
RBRicardo Moreira Borges
Ricardo Moreira Borges
NNNatália Pessoa Noyma
Natália Pessoa Noyma
Ernani PintoErnani Pinto
Ernani Pinto

24 June 2025 in Toxins
Verified
Journal Article
Open access
PDF file
EAEryka Costa Almeida
Eryka Costa Almeida
FJFernanda Simpósio Jacinavicius
Fernanda Simpósio Jacinavicius
Rhuana Valdetario Valdetário MediceRhuana Valdetario Valdetário Medice
Rhuana Valdetario Valdetário Medice
RMRafaella Bizo Menezes
Rafaella Bizo Menezes
LPLarissa Passos
Larissa Passos
Ernani PintoErnani Pinto
Ernani Pinto
Cyanobacterial blooms are becoming increasingly frequent and intense worldwide, often dominated by Microcystis aeruginosa, a species capable of producing a wide array of bioactive metabolites beyond microcystins. This study evaluates the ecotoxicological potential of a non-microcystin-producing strain, M. aeruginosa CCIBt3106, using acute immobilization assays with three microcrustacean species: Daphnia similis, Artemia salina, and Parhyale hawaiensis. Biomass was extracted using solvents of varying polarity, and selected extracts (aqueous and 50% methanol) were further fractionated and analyzed via high-resolution liquid chromatography–tandem mass spectrometry (HR-LC-MS/MS). Significant toxicity was observed in D. similis and P. hawaiensis, with EC50 values ranging from 660 to 940 µg mL−1. Metabolomic profiling revealed the presence of chemically diverse metabolite classes, including peptides, polyketides, and fatty acyls, with putative annotations linked to known bioactivities. These findings demonstrate that cyanobacterial strains lacking microcystins can still produce complex metabolite mixtures capable of inducing species-specific toxic effects under environmentally relevant exposure levels. Overall, the results highlight the need to expand ecotoxicological assessments and monitoring frameworks to include non-microcystin cyanobacterial metabolites and strains in water quality management.

22 September 2025 in Chemistry & Biodiversity
Verified
Journal Article
Open access
SASamuel Cavalcante do Amaral
Samuel Cavalcante do Amaral
LXLuciana Xavier
Luciana Xavier
MRMariana Reis
Mariana Reis
Rhuana Valdetario Valdetário MediceRhuana Valdetario Valdetário Medice
Rhuana Valdetario Valdetário Medice
JBJanaína Morone Bavini
Janaína Morone Bavini
ASAgenor Santos
Agenor Santos
Cyanobacteria are photosynthetic microorganisms known for producing diverse bioactive compounds. This study explores the bioactivity of extracts and fractions from Amazonian cyanobacteria and their pigment and phenolic compound production. A fraction from Synechococcus sp. CACIAM 05 showed cytotoxicity against hCMEC/D3 and MG‐63 cells. UPLC‐HRMS/MS analysis of this fraction (C5FD) identified pheophytin and phorbide derivatives as key bioactive molecules. In antimicrobial assays, another fraction from the same strain exhibited bactericidal activity against Bacillus subtilis ATCC 6633, with a MIC of 40 µg mL −1 . Additional strains also showed antibacterial effects, though with higher MICs. Allelopathic activity identified eleven bioactive strains, including a synergistic effect between Desmonostoc sp. CACIAM 45 and Synechocystis sp. CACIAM 05. Aqueous extracts from Lyngbya sp. CACIAM 07 and Desmonostoc sp. CACIAM 45 showed the highest total phenolic content. Cultivation of Desmonostoc sp. CACIAM 45 in different media indicated CHU‐10 and ASM as optimal for phenolic and phycobiliprotein production. These findings contribute to the field by unveiling novel bioactivities and metabolic profiles of Amazonian cyanobacteria, supporting their potential as a valuable source of natural products for pharmaceutical and biotechnological applications.

25 February 2026 in ChemBioChem
Verified
Journal Article
Open access
LRLaíne Santos Ribeiro
Laíne Santos Ribeiro
Rhuana Valdetario Valdetário MediceRhuana Valdetario Valdetário Medice
Rhuana Valdetario Valdetário Medice
JBJanaína Morone Bavini
Janaína Morone Bavini
CCCamila Manoel Crnkovic
Camila Manoel Crnkovic
SASamuel Cavalcante do Amaral
Samuel Cavalcante do Amaral
Biogenic nanoparticles are distinguished by their unique physical and chemical attributes, notably their potent antimicrobial activity against bacterial and fungal pathogens, as well as their cytotoxic effects on cancer cells. These nanoparticles are characterized by their biocompatibility, indicating their potential as effective antimicrobial agents and in oncological therapies. This article examines the existing literature on the antimicrobial and cytotoxic properties of nanoparticles derived from cyanobacteria, with particular emphasis on their implications for human health.

25 February 2026
Verified
Journal Article
Open access
LRLaíne Santos Ribeiro
Laíne Santos Ribeiro
Rhuana Valdetario Valdetário MediceRhuana Valdetario Valdetário Medice
Rhuana Valdetario Valdetário Medice
JBJanaína Morone Bavini
Janaína Morone Bavini
CCCamila Manoel Crnkovic
Camila Manoel Crnkovic
SASamuel Cavalcante do Amaral
Samuel Cavalcante do Amaral
Biogenic nanoparticles are distinguished by their unique physical and chemical attributes, notably their potent antimicrobial activity against bacterial and fungal pathogens, as well as their cytotoxic effects on cancer cells. These nanoparticles are characterized by their biocompatibility, indicating their potential as effective antimicrobial agents and in oncological therapies. This article examines the existing literature on the antimicrobial and cytotoxic properties of nanoparticles derived from cyanobacteria, with particular emphasis on their implications for human health.